MPTs

  • The Future of ARV-Based Prevention and More

    The pipeline of non-vaccine HIV prevention products includes oral pills, vaginal rings, vaginal and rectal gels, vaginal films, long-acting injectable antiretrovirals, and more. Also pictured in this infographic are the range of multipurpose prevention technologies in development that aim to reduce the risk of HIV and sexually transmitted infections and/or provide effective contraception for women. 

  • Family Planning Evidence Brief: Expanding Contraceptive Choice

    This brief report, prepared by the World Health Organization for the 2017 Family Planning Summit, highlights evidence to support the expansion of contraceptive options for women, including multipurpose technologies.

  • MPT Product Development Database

    The searchable MPT Product Development Database includes multipurpose technology products that are currently available, as well as MPT products in active development.

  • Multipurpose Prevention Technologies for the Developing World: U.S. Investment is Critical

    Published in the Guttmacher Policy Review in the summer of 2015, this article makes the case for greater investment in the development of multipurpose prevention technologies (MPTs) that would provide protection against multiple health risks, such as unintended pregnancy, HIV, and sexually transmitted infections. No large pharmaceutical company has a significant program in MPT research, so the development of these promising products depends on support from governments and foundations.